Literature DB >> 2383278

N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain.

N Minamino1, K Kangawa, H Matsuo.   

Abstract

C-type natriuretic peptide of 22 residues (CNP-22) is very recently identified in porcine brain as a third member of the mammalian natriuretic peptide family (1). Using a radioimmunoassay system newly established for CNP-22, we searched for CNP-related peptides in porcine brain. In addition to CNP-22, one major form of immunoreactive CNP was detected in porcine brain extracts, being isolated by immunoaffinity chromatography and reverse phase high performance liquid chromatography. By microsequence analysis, the peptide was deduced to be a 53-amino acid peptide carrying a CNP-22 sequence at the C-terminus, and was designated C-type natriuretic peptide-53 (CNP-53). CNP-53 was found to be a major molecular form of CNP in porcine brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383278     DOI: 10.1016/0006-291x(90)92187-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin-potentiating peptides and a C-type natriuretic peptide.

Authors:  N Murayama; M A Hayashi; H Ohi; L A Ferreira; V V Hermann; H Saito; Y Fujita; S Higuchi; B L Fernandes; T Yamane; A C de Camargo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 2.  Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart.

Authors:  Akihiro Yasoda
Journal:  Biology (Basel)       Date:  2022-06-14

3.  Cell-type-specific function of the C-type natriuretic peptide gene promoter in rat anterior pituitary-derived cultured cell lines.

Authors:  S Ohta; Y Shimekake; K Nagata
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

Authors:  S Suga; K Nakao; H Itoh; Y Komatsu; Y Ogawa; N Hama; H Imura
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.

Authors:  Akihiro Yasoda; Hidetomo Kitamura; Toshihito Fujii; Eri Kondo; Naoaki Murao; Masako Miura; Naotetsu Kanamoto; Yasato Komatsu; Hiroshi Arai; Kazuwa Nakao
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.

Authors:  A J Kenny; A Bourne; J Ingram
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

7.  ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.

Authors:  Naomi Morozumi; Takafumi Yotsumoto; Akira Yamaki; Kazunori Yoshikiyo; Sayaka Yoshida; Ryuichi Nakamura; Toshimasa Jindo; Mayumi Furuya; Hiroaki Maeda; Yoshiharu Minamitake; Kenji Kangawa
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.